Investment Q&A

Q: Still trying to figure out what to do with these healthcare names. Poor momentum and healthcare is unloved. If I sell I can move to something that's working and still sell with gain. Is this the wrong thinking because one should always have exposure to healthcare, even if it is not doing well? I have lots of tech, industrials, financials, and materials, but do have exposure to some healthcare in each portfolio I'm managing.

Q: Hello
Could you comment on latest AFRM holdings earnings?

Thank you
Stephane

Q: Morning 5i Team,
I currently hold both MCO and BLK and I am thinking moving selling MCO and put the money on BLK. Would like to get your thoughts on this intended move.
Thanks,
H

Q: I request an update on my previous inquiry from January 28 regarding Abbott Laboratories (ABT). Following your previous comments, I maintained my position; however, the stock has since declined significantly—falling from ~$106 to the mid-$80s, an 18-20% drop in just three months.
I am becoming increasingly unclear as to what exactly ails this company. While management points to the long-term potential of the Exact Sciences acquisition and new product launches like Volt PFA, the market’s reaction suggests deep skepticism. Specifically, I am concerned about:
- Operational Execution: The recent Class I recall of the Libre 3 sensors and the cautious 2026 guidance revision (citing dilution and nutrition segment weakness) have made me dubious about current management’s ability to navigate these complexities.
- Regulatory & Policy Risk: I have growing concerns regarding erratic and unclear US government policies impacting the medical device industry. How much of this "policy noise" is structural versus temporary (if anyone can tell) ?
- Analyst Sentiment vs. Price Action: Despite the price collapse, the analyst community seems to remain largely "Buy" rated with high price targets. Given the clear "thesis/technical divergence," is this a case of analysts being behind the curve, or is the stock genuinely oversold?
I am no longer keen on redeploying capital into the same sector. Given these factors, would you continue to ride out this volatility for the remainder of 2026, or has the fundamental story deteriorated enough to warrant an exit? (held in tax-deferred account)
I look forward to your insights and updated perspective. :ao:

Q: Hi Guys

Any idea why Intuitive Surgical is down 5% today?

Thanks

Stuart

Q: I seek your comments and perspective on iShares U.S. Medical Devices ETF - IHI. I have held IHI in a taxable account for a decade and have a taxable gain. However, it is now five years that the ETF has experienced significant stagnation. Total return over five years is negative. I am familiar with the products and services of major holdings such as Abbott Laboratories (ABT), Thermo Fisher Scientific (TMO), and Medtronic (MDT). But these companies have faced considerable headwinds, leading to consistent underperformance relative to the broader healthcare sector and the S&P 500.
I am weighing an exit against the following factors:
- Fundamental Quality: The underlying companies seem to possess moats and, theoretically, remain excellent businesses. Your thoughts?
- Macro Tailwinds: Worldwide demographic shifts and an aging population seem to provide a long-term structural advantage for the medical device industry. Your opinion?
- Timing: I am concerned about cashing out just before recovery or "take-off" for high-quality names held in the ETF. ( I seem skilled in selling only to see shares increase in valuations by 25% or more).
Given the current technical and fundamental landscape, in your opinion, is a holding period of 12 to 18 months likely to reward continued patience? Does the "thesis/technical divergence" we’ve seen in these large-cap medical device names suggest a turnaround is imminent, or is the opportunity cost of holding IHI still too high compared to other growth or value catalysts in the market?
I look forward to your insights on whether the narrative justifies remaining patient with this ETF.
:ao:

Q: Hello 5i,

We had set a target of 7,280 for the S&P to begin shuffling to a more defensive portfolio. We delayed the change as we wait for a response from Iran as there may be a small hypercycle for a couple days.

IF there is an agreement, which sectors may increase the most and other than oil is there any other sectors who may be negatively affected. We thought that fertilizer and metals may decrease with oil price declines.

Do you have a few specific stocks or etf's that could be vaulted with an agreement.

Thank you
D&J

Q: Is $CPNG interesting here after earnings drop due to data breach? It's a one time event. Or still an avoid?

Q: Thoughts on their quarter and long term outlook?

Q: Do you think SpaceX OpenAI and Anthropic will go Public with IPOs in the next 12 months and what impact do you see it having on the market based on the size of their likely offerings?

Seems these days by the time an IPO hits the market alot of the easy money has been made by those who have participated in Pre IPO offerings and Seed money.

Are there holdings related to any of these entities already in the market in funds held by those like Cathy Wood's Ark fund that one can realize the value of the shares prior to a Public IPO?

Q: Do you have a preference between Micron, Terradyne and Celestica? If I were to purchase an equal weight for all 3 how long is the time frame for each in this AI buildout

Q: What is your view of Domino's at this point in time? Do you think a smallish position is worth holding onto, or is it better to switch into another US consumer discretionary stock for a long-term hold?

Q: Thoughts about DRAM etf?

Q: You mentioned recently re. Micron, that it "can only meet 50% to 60% of customer demand". Can you say more about this? How much can MU ramp up memory production to meet this demand? Or is it more a story of demand likely to continue longer? Is there a high barrier to entry for others who might want to fill some of this demand? Thanks.

Q: Which of the two would you prefer for a +5 year hold? A reason please

If not these two, which are your favourite US non tech names for +5 years. Growth focused

Thank you!

Q: Another merger for TWO. Any thoughts on this one? Seems like all cash. Thanks again.

Q: I just added NWN yesterday for long term stability ( dividend king) +sector diversification.Although "strong first quarter results " are announced today, this stock drops 5% (am) .. What is your impression , is it still considered as an acceptable position according to my goals ?

Q: Adentra released results last night. Any thoughts? Seems like an OK company to me, but there isn't much growth in their business. When the economy is booming they make a lot of profit, but otherwise, it's rather boring. Dividend is OK, but nothing special, at 2%. Would you sell it if you held it?

Q: Hi 5i Team,

What's your take on the above 2 companies? Is it a buy, hold or sell and please provide rationale for your recommendations.

Thanks,
H

Q: Do you think MU still has lots of room left to run? What would you expect for upside is someone was investing now? 3 year hold.